Global Genomic Cancer Testing Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Genomic Cancer Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Genomic Cancer Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Genomic Cancer Testing market in any manner.
Global Genomic Cancer Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Market Segmentation (by Type)
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Market Segmentation (by Application)
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Genomic Cancer Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Genomic Cancer Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Genomic Cancer Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Genomic Cancer Testing market in any manner.
Global Genomic Cancer Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Market Segmentation (by Type)
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Market Segmentation (by Application)
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Genomic Cancer Testing Market
- Overview of the regional outlook of the Genomic Cancer Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Genomic Cancer Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Genomic Cancer Testing
1.2 Key Market Segments
1.2.1 Genomic Cancer Testing Segment by Type
1.2.2 Genomic Cancer Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENOMIC CANCER TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Genomic Cancer Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Genomic Cancer Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENOMIC CANCER TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Genomic Cancer Testing Sales by Manufacturers (2019-2024)
3.2 Global Genomic Cancer Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Genomic Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Genomic Cancer Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Genomic Cancer Testing Sales Sites, Area Served, Product Type
3.6 Genomic Cancer Testing Market Competitive Situation and Trends
3.6.1 Genomic Cancer Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Genomic Cancer Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GENOMIC CANCER TESTING INDUSTRY CHAIN ANALYSIS
4.1 Genomic Cancer Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENOMIC CANCER TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GENOMIC CANCER TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Genomic Cancer Testing Sales Market Share by Type (2019-2024)
6.3 Global Genomic Cancer Testing Market Size Market Share by Type (2019-2024)
6.4 Global Genomic Cancer Testing Price by Type (2019-2024)
7 GENOMIC CANCER TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Genomic Cancer Testing Market Sales by Application (2019-2024)
7.3 Global Genomic Cancer Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Genomic Cancer Testing Sales Growth Rate by Application (2019-2024)
8 GENOMIC CANCER TESTING MARKET SEGMENTATION BY REGION
8.1 Global Genomic Cancer Testing Sales by Region
8.1.1 Global Genomic Cancer Testing Sales by Region
8.1.2 Global Genomic Cancer Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Genomic Cancer Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Genomic Cancer Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Genomic Cancer Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Genomic Cancer Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Genomic Cancer Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Devyser
9.1.1 Devyser Genomic Cancer Testing Basic Information
9.1.2 Devyser Genomic Cancer Testing Product Overview
9.1.3 Devyser Genomic Cancer Testing Product Market Performance
9.1.4 Devyser Business Overview
9.1.5 Devyser Genomic Cancer Testing SWOT Analysis
9.1.6 Devyser Recent Developments
9.2 Agendia
9.2.1 Agendia Genomic Cancer Testing Basic Information
9.2.2 Agendia Genomic Cancer Testing Product Overview
9.2.3 Agendia Genomic Cancer Testing Product Market Performance
9.2.4 Agendia Business Overview
9.2.5 Agendia Genomic Cancer Testing SWOT Analysis
9.2.6 Agendia Recent Developments
9.3 Illumina
9.3.1 Illumina Genomic Cancer Testing Basic Information
9.3.2 Illumina Genomic Cancer Testing Product Overview
9.3.3 Illumina Genomic Cancer Testing Product Market Performance
9.3.4 Illumina Genomic Cancer Testing SWOT Analysis
9.3.5 Illumina Business Overview
9.3.6 Illumina Recent Developments
9.4 Personal Genome Diagnostics
9.4.1 Personal Genome Diagnostics Genomic Cancer Testing Basic Information
9.4.2 Personal Genome Diagnostics Genomic Cancer Testing Product Overview
9.4.3 Personal Genome Diagnostics Genomic Cancer Testing Product Market Performance
9.4.4 Personal Genome Diagnostics Business Overview
9.4.5 Personal Genome Diagnostics Recent Developments
9.5 Veracyte
9.5.1 Veracyte Genomic Cancer Testing Basic Information
9.5.2 Veracyte Genomic Cancer Testing Product Overview
9.5.3 Veracyte Genomic Cancer Testing Product Market Performance
9.5.4 Veracyte Business Overview
9.5.5 Veracyte Recent Developments
9.6 Pacific Biosciences of California
9.6.1 Pacific Biosciences of California Genomic Cancer Testing Basic Information
9.6.2 Pacific Biosciences of California Genomic Cancer Testing Product Overview
9.6.3 Pacific Biosciences of California Genomic Cancer Testing Product Market Performance
9.6.4 Pacific Biosciences of California Business Overview
9.6.5 Pacific Biosciences of California Recent Developments
9.7 Qiagen
9.7.1 Qiagen Genomic Cancer Testing Basic Information
9.7.2 Qiagen Genomic Cancer Testing Product Overview
9.7.3 Qiagen Genomic Cancer Testing Product Market Performance
9.7.4 Qiagen Business Overview
9.7.5 Qiagen Recent Developments
9.8 Agilent Technologies
9.8.1 Agilent Technologies Genomic Cancer Testing Basic Information
9.8.2 Agilent Technologies Genomic Cancer Testing Product Overview
9.8.3 Agilent Technologies Genomic Cancer Testing Product Market Performance
9.8.4 Agilent Technologies Business Overview
9.8.5 Agilent Technologies Recent Developments
9.9 Natera
9.9.1 Natera Genomic Cancer Testing Basic Information
9.9.2 Natera Genomic Cancer Testing Product Overview
9.9.3 Natera Genomic Cancer Testing Product Market Performance
9.9.4 Natera Business Overview
9.9.5 Natera Recent Developments
9.10 Bio Rad Laboratories
9.10.1 Bio Rad Laboratories Genomic Cancer Testing Basic Information
9.10.2 Bio Rad Laboratories Genomic Cancer Testing Product Overview
9.10.3 Bio Rad Laboratories Genomic Cancer Testing Product Market Performance
9.10.4 Bio Rad Laboratories Business Overview
9.10.5 Bio Rad Laboratories Recent Developments
9.11 Myriad Genetics
9.11.1 Myriad Genetics Genomic Cancer Testing Basic Information
9.11.2 Myriad Genetics Genomic Cancer Testing Product Overview
9.11.3 Myriad Genetics Genomic Cancer Testing Product Market Performance
9.11.4 Myriad Genetics Business Overview
9.11.5 Myriad Genetics Recent Developments
10 GENOMIC CANCER TESTING MARKET FORECAST BY REGION
10.1 Global Genomic Cancer Testing Market Size Forecast
10.2 Global Genomic Cancer Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Genomic Cancer Testing Market Size Forecast by Country
10.2.3 Asia Pacific Genomic Cancer Testing Market Size Forecast by Region
10.2.4 South America Genomic Cancer Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Genomic Cancer Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Genomic Cancer Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Genomic Cancer Testing by Type (2025-2030)
11.1.2 Global Genomic Cancer Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Genomic Cancer Testing by Type (2025-2030)
11.2 Global Genomic Cancer Testing Market Forecast by Application (2025-2030)
11.2.1 Global Genomic Cancer Testing Sales (K Units) Forecast by Application
11.2.2 Global Genomic Cancer Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Genomic Cancer Testing
1.2 Key Market Segments
1.2.1 Genomic Cancer Testing Segment by Type
1.2.2 Genomic Cancer Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENOMIC CANCER TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Genomic Cancer Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Genomic Cancer Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENOMIC CANCER TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Genomic Cancer Testing Sales by Manufacturers (2019-2024)
3.2 Global Genomic Cancer Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Genomic Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Genomic Cancer Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Genomic Cancer Testing Sales Sites, Area Served, Product Type
3.6 Genomic Cancer Testing Market Competitive Situation and Trends
3.6.1 Genomic Cancer Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Genomic Cancer Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GENOMIC CANCER TESTING INDUSTRY CHAIN ANALYSIS
4.1 Genomic Cancer Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENOMIC CANCER TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GENOMIC CANCER TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Genomic Cancer Testing Sales Market Share by Type (2019-2024)
6.3 Global Genomic Cancer Testing Market Size Market Share by Type (2019-2024)
6.4 Global Genomic Cancer Testing Price by Type (2019-2024)
7 GENOMIC CANCER TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Genomic Cancer Testing Market Sales by Application (2019-2024)
7.3 Global Genomic Cancer Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Genomic Cancer Testing Sales Growth Rate by Application (2019-2024)
8 GENOMIC CANCER TESTING MARKET SEGMENTATION BY REGION
8.1 Global Genomic Cancer Testing Sales by Region
8.1.1 Global Genomic Cancer Testing Sales by Region
8.1.2 Global Genomic Cancer Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Genomic Cancer Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Genomic Cancer Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Genomic Cancer Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Genomic Cancer Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Genomic Cancer Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Devyser
9.1.1 Devyser Genomic Cancer Testing Basic Information
9.1.2 Devyser Genomic Cancer Testing Product Overview
9.1.3 Devyser Genomic Cancer Testing Product Market Performance
9.1.4 Devyser Business Overview
9.1.5 Devyser Genomic Cancer Testing SWOT Analysis
9.1.6 Devyser Recent Developments
9.2 Agendia
9.2.1 Agendia Genomic Cancer Testing Basic Information
9.2.2 Agendia Genomic Cancer Testing Product Overview
9.2.3 Agendia Genomic Cancer Testing Product Market Performance
9.2.4 Agendia Business Overview
9.2.5 Agendia Genomic Cancer Testing SWOT Analysis
9.2.6 Agendia Recent Developments
9.3 Illumina
9.3.1 Illumina Genomic Cancer Testing Basic Information
9.3.2 Illumina Genomic Cancer Testing Product Overview
9.3.3 Illumina Genomic Cancer Testing Product Market Performance
9.3.4 Illumina Genomic Cancer Testing SWOT Analysis
9.3.5 Illumina Business Overview
9.3.6 Illumina Recent Developments
9.4 Personal Genome Diagnostics
9.4.1 Personal Genome Diagnostics Genomic Cancer Testing Basic Information
9.4.2 Personal Genome Diagnostics Genomic Cancer Testing Product Overview
9.4.3 Personal Genome Diagnostics Genomic Cancer Testing Product Market Performance
9.4.4 Personal Genome Diagnostics Business Overview
9.4.5 Personal Genome Diagnostics Recent Developments
9.5 Veracyte
9.5.1 Veracyte Genomic Cancer Testing Basic Information
9.5.2 Veracyte Genomic Cancer Testing Product Overview
9.5.3 Veracyte Genomic Cancer Testing Product Market Performance
9.5.4 Veracyte Business Overview
9.5.5 Veracyte Recent Developments
9.6 Pacific Biosciences of California
9.6.1 Pacific Biosciences of California Genomic Cancer Testing Basic Information
9.6.2 Pacific Biosciences of California Genomic Cancer Testing Product Overview
9.6.3 Pacific Biosciences of California Genomic Cancer Testing Product Market Performance
9.6.4 Pacific Biosciences of California Business Overview
9.6.5 Pacific Biosciences of California Recent Developments
9.7 Qiagen
9.7.1 Qiagen Genomic Cancer Testing Basic Information
9.7.2 Qiagen Genomic Cancer Testing Product Overview
9.7.3 Qiagen Genomic Cancer Testing Product Market Performance
9.7.4 Qiagen Business Overview
9.7.5 Qiagen Recent Developments
9.8 Agilent Technologies
9.8.1 Agilent Technologies Genomic Cancer Testing Basic Information
9.8.2 Agilent Technologies Genomic Cancer Testing Product Overview
9.8.3 Agilent Technologies Genomic Cancer Testing Product Market Performance
9.8.4 Agilent Technologies Business Overview
9.8.5 Agilent Technologies Recent Developments
9.9 Natera
9.9.1 Natera Genomic Cancer Testing Basic Information
9.9.2 Natera Genomic Cancer Testing Product Overview
9.9.3 Natera Genomic Cancer Testing Product Market Performance
9.9.4 Natera Business Overview
9.9.5 Natera Recent Developments
9.10 Bio Rad Laboratories
9.10.1 Bio Rad Laboratories Genomic Cancer Testing Basic Information
9.10.2 Bio Rad Laboratories Genomic Cancer Testing Product Overview
9.10.3 Bio Rad Laboratories Genomic Cancer Testing Product Market Performance
9.10.4 Bio Rad Laboratories Business Overview
9.10.5 Bio Rad Laboratories Recent Developments
9.11 Myriad Genetics
9.11.1 Myriad Genetics Genomic Cancer Testing Basic Information
9.11.2 Myriad Genetics Genomic Cancer Testing Product Overview
9.11.3 Myriad Genetics Genomic Cancer Testing Product Market Performance
9.11.4 Myriad Genetics Business Overview
9.11.5 Myriad Genetics Recent Developments
10 GENOMIC CANCER TESTING MARKET FORECAST BY REGION
10.1 Global Genomic Cancer Testing Market Size Forecast
10.2 Global Genomic Cancer Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Genomic Cancer Testing Market Size Forecast by Country
10.2.3 Asia Pacific Genomic Cancer Testing Market Size Forecast by Region
10.2.4 South America Genomic Cancer Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Genomic Cancer Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Genomic Cancer Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Genomic Cancer Testing by Type (2025-2030)
11.1.2 Global Genomic Cancer Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Genomic Cancer Testing by Type (2025-2030)
11.2 Global Genomic Cancer Testing Market Forecast by Application (2025-2030)
11.2.1 Global Genomic Cancer Testing Sales (K Units) Forecast by Application
11.2.2 Global Genomic Cancer Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Genomic Cancer Testing Market Size Comparison by Region (M USD)
Table 5. Global Genomic Cancer Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Genomic Cancer Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Genomic Cancer Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Genomic Cancer Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Cancer Testing as of 2022)
Table 10. Global Market Genomic Cancer Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Genomic Cancer Testing Sales Sites and Area Served
Table 12. Manufacturers Genomic Cancer Testing Product Type
Table 13. Global Genomic Cancer Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Genomic Cancer Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Genomic Cancer Testing Market Challenges
Table 22. Global Genomic Cancer Testing Sales by Type (K Units)
Table 23. Global Genomic Cancer Testing Market Size by Type (M USD)
Table 24. Global Genomic Cancer Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Genomic Cancer Testing Sales Market Share by Type (2019-2024)
Table 26. Global Genomic Cancer Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Genomic Cancer Testing Market Size Share by Type (2019-2024)
Table 28. Global Genomic Cancer Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Genomic Cancer Testing Sales (K Units) by Application
Table 30. Global Genomic Cancer Testing Market Size by Application
Table 31. Global Genomic Cancer Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Genomic Cancer Testing Sales Market Share by Application (2019-2024)
Table 33. Global Genomic Cancer Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Genomic Cancer Testing Market Share by Application (2019-2024)
Table 35. Global Genomic Cancer Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Genomic Cancer Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Genomic Cancer Testing Sales Market Share by Region (2019-2024)
Table 38. North America Genomic Cancer Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Genomic Cancer Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Genomic Cancer Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Genomic Cancer Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Genomic Cancer Testing Sales by Region (2019-2024) & (K Units)
Table 43. Devyser Genomic Cancer Testing Basic Information
Table 44. Devyser Genomic Cancer Testing Product Overview
Table 45. Devyser Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Devyser Business Overview
Table 47. Devyser Genomic Cancer Testing SWOT Analysis
Table 48. Devyser Recent Developments
Table 49. Agendia Genomic Cancer Testing Basic Information
Table 50. Agendia Genomic Cancer Testing Product Overview
Table 51. Agendia Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Agendia Business Overview
Table 53. Agendia Genomic Cancer Testing SWOT Analysis
Table 54. Agendia Recent Developments
Table 55. Illumina Genomic Cancer Testing Basic Information
Table 56. Illumina Genomic Cancer Testing Product Overview
Table 57. Illumina Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Illumina Genomic Cancer Testing SWOT Analysis
Table 59. Illumina Business Overview
Table 60. Illumina Recent Developments
Table 61. Personal Genome Diagnostics Genomic Cancer Testing Basic Information
Table 62. Personal Genome Diagnostics Genomic Cancer Testing Product Overview
Table 63. Personal Genome Diagnostics Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Personal Genome Diagnostics Business Overview
Table 65. Personal Genome Diagnostics Recent Developments
Table 66. Veracyte Genomic Cancer Testing Basic Information
Table 67. Veracyte Genomic Cancer Testing Product Overview
Table 68. Veracyte Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Veracyte Business Overview
Table 70. Veracyte Recent Developments
Table 71. Pacific Biosciences of California Genomic Cancer Testing Basic Information
Table 72. Pacific Biosciences of California Genomic Cancer Testing Product Overview
Table 73. Pacific Biosciences of California Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Pacific Biosciences of California Business Overview
Table 75. Pacific Biosciences of California Recent Developments
Table 76. Qiagen Genomic Cancer Testing Basic Information
Table 77. Qiagen Genomic Cancer Testing Product Overview
Table 78. Qiagen Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Qiagen Business Overview
Table 80. Qiagen Recent Developments
Table 81. Agilent Technologies Genomic Cancer Testing Basic Information
Table 82. Agilent Technologies Genomic Cancer Testing Product Overview
Table 83. Agilent Technologies Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Agilent Technologies Business Overview
Table 85. Agilent Technologies Recent Developments
Table 86. Natera Genomic Cancer Testing Basic Information
Table 87. Natera Genomic Cancer Testing Product Overview
Table 88. Natera Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Natera Business Overview
Table 90. Natera Recent Developments
Table 91. Bio Rad Laboratories Genomic Cancer Testing Basic Information
Table 92. Bio Rad Laboratories Genomic Cancer Testing Product Overview
Table 93. Bio Rad Laboratories Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Bio Rad Laboratories Business Overview
Table 95. Bio Rad Laboratories Recent Developments
Table 96. Myriad Genetics Genomic Cancer Testing Basic Information
Table 97. Myriad Genetics Genomic Cancer Testing Product Overview
Table 98. Myriad Genetics Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Myriad Genetics Business Overview
Table 100. Myriad Genetics Recent Developments
Table 101. Global Genomic Cancer Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global Genomic Cancer Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Genomic Cancer Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America Genomic Cancer Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Genomic Cancer Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe Genomic Cancer Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Genomic Cancer Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific Genomic Cancer Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Genomic Cancer Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America Genomic Cancer Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Genomic Cancer Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Genomic Cancer Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Genomic Cancer Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global Genomic Cancer Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Genomic Cancer Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global Genomic Cancer Testing Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global Genomic Cancer Testing Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Genomic Cancer Testing Market Size Comparison by Region (M USD)
Table 5. Global Genomic Cancer Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Genomic Cancer Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Genomic Cancer Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Genomic Cancer Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Cancer Testing as of 2022)
Table 10. Global Market Genomic Cancer Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Genomic Cancer Testing Sales Sites and Area Served
Table 12. Manufacturers Genomic Cancer Testing Product Type
Table 13. Global Genomic Cancer Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Genomic Cancer Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Genomic Cancer Testing Market Challenges
Table 22. Global Genomic Cancer Testing Sales by Type (K Units)
Table 23. Global Genomic Cancer Testing Market Size by Type (M USD)
Table 24. Global Genomic Cancer Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Genomic Cancer Testing Sales Market Share by Type (2019-2024)
Table 26. Global Genomic Cancer Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Genomic Cancer Testing Market Size Share by Type (2019-2024)
Table 28. Global Genomic Cancer Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Genomic Cancer Testing Sales (K Units) by Application
Table 30. Global Genomic Cancer Testing Market Size by Application
Table 31. Global Genomic Cancer Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Genomic Cancer Testing Sales Market Share by Application (2019-2024)
Table 33. Global Genomic Cancer Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Genomic Cancer Testing Market Share by Application (2019-2024)
Table 35. Global Genomic Cancer Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Genomic Cancer Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Genomic Cancer Testing Sales Market Share by Region (2019-2024)
Table 38. North America Genomic Cancer Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Genomic Cancer Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Genomic Cancer Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Genomic Cancer Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Genomic Cancer Testing Sales by Region (2019-2024) & (K Units)
Table 43. Devyser Genomic Cancer Testing Basic Information
Table 44. Devyser Genomic Cancer Testing Product Overview
Table 45. Devyser Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Devyser Business Overview
Table 47. Devyser Genomic Cancer Testing SWOT Analysis
Table 48. Devyser Recent Developments
Table 49. Agendia Genomic Cancer Testing Basic Information
Table 50. Agendia Genomic Cancer Testing Product Overview
Table 51. Agendia Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Agendia Business Overview
Table 53. Agendia Genomic Cancer Testing SWOT Analysis
Table 54. Agendia Recent Developments
Table 55. Illumina Genomic Cancer Testing Basic Information
Table 56. Illumina Genomic Cancer Testing Product Overview
Table 57. Illumina Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Illumina Genomic Cancer Testing SWOT Analysis
Table 59. Illumina Business Overview
Table 60. Illumina Recent Developments
Table 61. Personal Genome Diagnostics Genomic Cancer Testing Basic Information
Table 62. Personal Genome Diagnostics Genomic Cancer Testing Product Overview
Table 63. Personal Genome Diagnostics Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Personal Genome Diagnostics Business Overview
Table 65. Personal Genome Diagnostics Recent Developments
Table 66. Veracyte Genomic Cancer Testing Basic Information
Table 67. Veracyte Genomic Cancer Testing Product Overview
Table 68. Veracyte Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Veracyte Business Overview
Table 70. Veracyte Recent Developments
Table 71. Pacific Biosciences of California Genomic Cancer Testing Basic Information
Table 72. Pacific Biosciences of California Genomic Cancer Testing Product Overview
Table 73. Pacific Biosciences of California Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Pacific Biosciences of California Business Overview
Table 75. Pacific Biosciences of California Recent Developments
Table 76. Qiagen Genomic Cancer Testing Basic Information
Table 77. Qiagen Genomic Cancer Testing Product Overview
Table 78. Qiagen Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Qiagen Business Overview
Table 80. Qiagen Recent Developments
Table 81. Agilent Technologies Genomic Cancer Testing Basic Information
Table 82. Agilent Technologies Genomic Cancer Testing Product Overview
Table 83. Agilent Technologies Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Agilent Technologies Business Overview
Table 85. Agilent Technologies Recent Developments
Table 86. Natera Genomic Cancer Testing Basic Information
Table 87. Natera Genomic Cancer Testing Product Overview
Table 88. Natera Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Natera Business Overview
Table 90. Natera Recent Developments
Table 91. Bio Rad Laboratories Genomic Cancer Testing Basic Information
Table 92. Bio Rad Laboratories Genomic Cancer Testing Product Overview
Table 93. Bio Rad Laboratories Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Bio Rad Laboratories Business Overview
Table 95. Bio Rad Laboratories Recent Developments
Table 96. Myriad Genetics Genomic Cancer Testing Basic Information
Table 97. Myriad Genetics Genomic Cancer Testing Product Overview
Table 98. Myriad Genetics Genomic Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Myriad Genetics Business Overview
Table 100. Myriad Genetics Recent Developments
Table 101. Global Genomic Cancer Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global Genomic Cancer Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Genomic Cancer Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America Genomic Cancer Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Genomic Cancer Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe Genomic Cancer Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Genomic Cancer Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific Genomic Cancer Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Genomic Cancer Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America Genomic Cancer Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Genomic Cancer Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Genomic Cancer Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Genomic Cancer Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global Genomic Cancer Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Genomic Cancer Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global Genomic Cancer Testing Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global Genomic Cancer Testing Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Genomic Cancer Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Genomic Cancer Testing Market Size (M USD), 2019-2030
Figure 5. Global Genomic Cancer Testing Market Size (M USD) (2019-2030)
Figure 6. Global Genomic Cancer Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Genomic Cancer Testing Market Size by Country (M USD)
Figure 11. Genomic Cancer Testing Sales Share by Manufacturers in 2023
Figure 12. Global Genomic Cancer Testing Revenue Share by Manufacturers in 2023
Figure 13. Genomic Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Genomic Cancer Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Genomic Cancer Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Genomic Cancer Testing Market Share by Type
Figure 18. Sales Market Share of Genomic Cancer Testing by Type (2019-2024)
Figure 19. Sales Market Share of Genomic Cancer Testing by Type in 2023
Figure 20. Market Size Share of Genomic Cancer Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Genomic Cancer Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Genomic Cancer Testing Market Share by Application
Figure 24. Global Genomic Cancer Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Genomic Cancer Testing Sales Market Share by Application in 2023
Figure 26. Global Genomic Cancer Testing Market Share by Application (2019-2024)
Figure 27. Global Genomic Cancer Testing Market Share by Application in 2023
Figure 28. Global Genomic Cancer Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Genomic Cancer Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Genomic Cancer Testing Sales Market Share by Country in 2023
Figure 32. U.S. Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Genomic Cancer Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Genomic Cancer Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Genomic Cancer Testing Sales Market Share by Country in 2023
Figure 37. Germany Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Genomic Cancer Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Genomic Cancer Testing Sales Market Share by Region in 2023
Figure 44. China Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Genomic Cancer Testing Sales and Growth Rate (K Units)
Figure 50. South America Genomic Cancer Testing Sales Market Share by Country in 2023
Figure 51. Brazil Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Genomic Cancer Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Genomic Cancer Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Genomic Cancer Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Genomic Cancer Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Genomic Cancer Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Genomic Cancer Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Genomic Cancer Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Genomic Cancer Testing Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Genomic Cancer Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Genomic Cancer Testing Market Size (M USD), 2019-2030
Figure 5. Global Genomic Cancer Testing Market Size (M USD) (2019-2030)
Figure 6. Global Genomic Cancer Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Genomic Cancer Testing Market Size by Country (M USD)
Figure 11. Genomic Cancer Testing Sales Share by Manufacturers in 2023
Figure 12. Global Genomic Cancer Testing Revenue Share by Manufacturers in 2023
Figure 13. Genomic Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Genomic Cancer Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Genomic Cancer Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Genomic Cancer Testing Market Share by Type
Figure 18. Sales Market Share of Genomic Cancer Testing by Type (2019-2024)
Figure 19. Sales Market Share of Genomic Cancer Testing by Type in 2023
Figure 20. Market Size Share of Genomic Cancer Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Genomic Cancer Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Genomic Cancer Testing Market Share by Application
Figure 24. Global Genomic Cancer Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Genomic Cancer Testing Sales Market Share by Application in 2023
Figure 26. Global Genomic Cancer Testing Market Share by Application (2019-2024)
Figure 27. Global Genomic Cancer Testing Market Share by Application in 2023
Figure 28. Global Genomic Cancer Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Genomic Cancer Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Genomic Cancer Testing Sales Market Share by Country in 2023
Figure 32. U.S. Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Genomic Cancer Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Genomic Cancer Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Genomic Cancer Testing Sales Market Share by Country in 2023
Figure 37. Germany Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Genomic Cancer Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Genomic Cancer Testing Sales Market Share by Region in 2023
Figure 44. China Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Genomic Cancer Testing Sales and Growth Rate (K Units)
Figure 50. South America Genomic Cancer Testing Sales Market Share by Country in 2023
Figure 51. Brazil Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Genomic Cancer Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Genomic Cancer Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Genomic Cancer Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Genomic Cancer Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Genomic Cancer Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Genomic Cancer Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Genomic Cancer Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Genomic Cancer Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Genomic Cancer Testing Market Share Forecast by Application (2025-2030)
